How to buy PolyPid stock

PolyPid Ltd is a biotechnology business based in the US. PolyPid shares (PYPD) are listed on the NASDAQ and all prices are listed in US Dollars. PolyPid employs 57 staff and has a market cap (total outstanding shares value) of USD$229 million.

How to buy shares in PolyPid

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for PolyPid. Find the stock by name or ticker symbol: PYPD. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PolyPid reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of PolyPid, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of PolyPid. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. PYPD shares summary
2. Compare share dealing platforms
3. Is PYPD stock a buy or sell?
4. Stock performance over time
5. Can I short PYPD shares?
6. PolyPid's financials
7. Does PolyPid pay a dividend?
8. Other common questions

PolyPid share price

Use our graph to track the performance of PYPD stocks over time.

PolyPid shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$8.64 - USD$19.45
50-day moving average	USD$11.2194
200-day moving average	USD$11.3886
Wall St. target price	USD$25.8
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-4.5105

Buy PolyPid shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PolyPid stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of PolyPid Ltd by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting PolyPid shares

There are currently 54,966 PolyPid shares held short by investors – that's known as PolyPid's "short interest". This figure is 8.8% up from 50,530 last month.

There are a few different ways that this level of interest in shorting PolyPid shares can be evaluated.

PolyPid's "short interest ratio" (SIR)

PolyPid's "short interest ratio" (SIR) is the quantity of PolyPid shares currently shorted divided by the average quantity of PolyPid shares traded daily (recently around 66224.096385542). PolyPid's SIR currently stands at 0.83. In other words for every 100,000 PolyPid shares traded daily on the market, roughly 830 shares are currently held short.

However PolyPid's short interest can also be evaluated against the total number of PolyPid shares, or, against the total number of tradable PolyPid shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PolyPid's short interest could be expressed as 0% of the outstanding shares (for every 100,000 PolyPid shares in existence, roughly 0 shares are currently held short) or 0.0042% of the tradable shares (for every 100,000 tradable PolyPid shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PolyPid.

Find out more about how you can short PolyPid stock.

PolyPid overview

PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in pivotal Phase 3 clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing PLEXONCO that is in preclinical studies for the treatment of cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petach Tikva, Israel.

Frequently asked questions

• What percentage of PolyPid is owned by insiders or institutions?

  Currently 1.098% of PolyPid shares are held by insiders and 6.127% by institutions.

• How many people work for PolyPid?

  Latest data suggests 57 work at PolyPid.

• When does the fiscal year end for PolyPid?

  PolyPid's fiscal year ends in December.

• Where is PolyPid based?

  PolyPid's address is: 18 Hasivim Street, Petah Tikva, Israel, 4959376

• What is PolyPid's ISIN number?

  PolyPid's international securities identification number is: IL0011326795